These 2 Healthcare Stocks Just Declared Dividend Raises

分组1 - Bristol Myers Squibb has a long history of paying dividends, with 94 consecutive years and 17 years of dividend raises, recently declaring a $0.63-per-share quarterly payout, marking a 1.6% increase [2] - The company focuses on developing drugs for cardiovascular disease, immune disorders, and oncology, with a portfolio divided into "growth" medications and "legacy" products [3] - The growth portfolio, led by cancer treatment Opdivo, saw a sales increase of 18% year over year to $6.9 billion, which helped offset a 12% drop in legacy revenue, resulting in an overall revenue increase of 3% to $12.2 billion [5] 分组2 - Bristol Myers Squibb generated over $5.9 billion in free cash flow in the third quarter, significantly exceeding the nearly $1.3 billion paid out in dividends, indicating strong financial health [6] - The company remains profitable with a non-GAAP net income of $3.3 billion, despite an 11% decline during the period [5]